Clinical Pharmacokinetics of Atogepant in Healthy Japanese and White Adults
Abstract Introduction Atogepant is a calcitonin gene-related peptide receptor antagonist approved for the preventive treatment of migraine in adults in the USA, EU, and several other countries. The objectives of this study were to evaluate the pharmacokinetics (PK) and dose proportionality of atogep...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2025-01-01
|
Series: | Neurology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40120-024-00699-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|